117
Views
20
CrossRef citations to date
0
Altmetric
Drug Evaluation

Vinflunine: clinical perspectives of an emerging anticancer agent

, BSc, , BSPharm MMedSc & , MBBS MS FRCS FACS
Pages 583-591 | Published online: 25 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xiaowen Zhou, Zeren Xu, Aijing Li, Zhengqiong Zhang & Sichuan Xu. (2019) Double-sides sticking mechanism of vinblastine interacting with α,β-tubulin to get activity against cancer cells. Journal of Biomolecular Structure and Dynamics 37:15, pages 4080-4091.
Read now
Shaoming Chi, Wei Xie, Jiwei Zhang & Sichuan Xu. (2015) Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin. Journal of Biomolecular Structure and Dynamics 33:10, pages 2234-2254.
Read now

Articles from other publishers (18)

Aakash Deep, Davinder Kumar, Nitin Bansal, Balasubramanian Narasimhan, Rakesh Kumar Marwaha & Prabodh Chander Sharma. (2023) Understanding mechanistic aspects and therapeutic potential of natural substances as anticancer agents. Phytomedicine Plus 3:2, pages 100418.
Crossref
Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism 507 546 .
Olagoke Zacchaeus Olatunde, Jianping Yong & Canzhong Lu. (2021) The Progress of the Anticancer Agents Related to the Microtubules Target. Mini-Reviews in Medicinal Chemistry 20:20, pages 2165-2192.
Crossref
Nadine Houédé & Gérard Milano. (2019) Deuxième ligne thérapeutique des cancers de vessie avancés : une place réelle pour la vinflunine. Bulletin du Cancer 106:5, pages 431-435.
Crossref
Emanuela Martino, Giuseppe Casamassima, Sonia Castiglione, Edoardo Cellupica, Serena Pantalone, Francesca Papagni, Marta Rui, Angela Marika Siciliano & Simona Collina. (2018) Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. Bioorganic & Medicinal Chemistry Letters 28:17, pages 2816-2826.
Crossref
Amal A A Alotaibi, Mojgan Najafzadeh, Justin D Davies, Adolf Baumgartner & Diana Anderson. (2017) Inhibition of survivin expression after using oxaliplatin and vinflunine to induce cytogenetic damage in vitro in lymphocytes from colon cancer patients and healthy individuals. Mutagenesis 32:5, pages 517-524.
Crossref
Anca Hermenean & Aurel Ardelean. 2017. Cytoskeleton - Structure, Dynamics, Function and Disease. Cytoskeleton - Structure, Dynamics, Function and Disease.
Tawnya C. McKee, Albert W. W. Van Wyk & Emily L. Whitson. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics 39 67 .
Andrea T. Hooper, Frank Loganzo, Chad May & Hans-Peter Gerber. 2013. Natural Products and Cancer Drug Discovery. Natural Products and Cancer Drug Discovery 17 38 .
Susana M. Campos & Don S. Dizon. (2012) Antimitotic Inhibitors. Hematology/Oncology Clinics of North America 26:3, pages 607-628.
Crossref
Simon Cotton. 2011. Every Molecule Tells a Story. Every Molecule Tells a Story 190 213 .
Hanna K. Sanoff, Janine M. Davies, Christine Walko, William Irvin, Larry Buie, Kimberly Keller, Anastasia Ivanova, Wing-Keung Chiu, Bert H. O’Neil, Thomas E. Stinchcombe & E. Claire Dees. (2010) A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors. Investigational New Drugs 29:5, pages 978-983.
Crossref
Claire Lopez, Bérengère Claude, Philippe Morin, Martine Pelissou, Richard Pena, Jean-Paul Max & Jean-Paul Ribet. (2011) Synthesis and study of a molecularly imprinted polymer for specific solid-phase extraction of vinflunine and its metabolite from biological fluids. Journal of Separation Science 34:15, pages 1902-1909.
Crossref
Grégoire Zorza, Delphine Pellerin, Valérie Fortune & Christian Puozzo. (2010) A Simple and Sensitive High-Performance Liquid Chromatographic Method for the Determination of Vinflunine and 4-O-Deacetylvinflunine From Human Blood. Therapeutic Drug Monitoring 32:6, pages 734-740.
Crossref
J.C. Soria, C. Massard & T. Le Chevalier. (2010) Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?. Annals of Oncology 21:12, pages 2324-2332.
Crossref
L. M. Skivka, G. V. Gorbik, O. G. Fedorchuk & V. V. Pozur. (2009) Tumor-associated macrophages in the prospect of development of targeted anticancer. Cytology and Genetics 43:4, pages 283-292.
Crossref
April L. Risinger, Francis J. Giles & Susan L. Mooberry. (2009) Microtubule dynamics as a target in oncology. Cancer Treatment Reviews 35:3, pages 255-261.
Crossref
Xuyi Yue, Xingang Zhang & Feng-Ling Qing. (2008) Highly Diastereoselective Zn/SnCl 2 -Mediated gem -Difluoroallylation of Chiral Hydrazones . Organic Letters 11:1, pages 73-76.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.